|
|
|
Volumn 14, Issue 4, 2001, Pages 68-80
|
|
Evidence-based guidelines for treatment of bacterial respiratory tract infections in the era of antibiotic resistance.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
ANTIBIOTIC RESISTANCE;
ARTICLE;
CLASSIFICATION;
COST OF ILLNESS;
DISEASE MANAGEMENT;
DRUG EFFECT;
DRUG UTILIZATION;
ECONOMICS;
EVIDENCE BASED MEDICINE;
HAEMOPHILUS INFLUENZAE;
HUMAN;
MICROBIOLOGICAL EXAMINATION;
MORAXELLA CATARRHALIS;
PRACTICE GUIDELINE;
PREVALENCE;
RESPIRATORY TRACT INFECTION;
STANDARD;
STREPTOCOCCUS PNEUMONIAE;
UNITED STATES;
VIROLOGY;
ANTI-BACTERIAL AGENTS;
COST OF ILLNESS;
DISEASE MANAGEMENT;
DRUG RESISTANCE, MICROBIAL;
DRUG UTILIZATION;
EVIDENCE-BASED MEDICINE;
HAEMOPHILUS INFLUENZAE;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
MORAXELLA (BRANHAMELLA) CATARRHALIS;
PRACTICE GUIDELINES;
PREVALENCE;
RESPIRATORY TRACT INFECTIONS;
STREPTOCOCCUS PNEUMONIAE;
UNITED STATES;
|
|
EID: 0035316055
PISSN: 10965645
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (8)
|
|
References (0)
|
